Two international speakers, Dr. Dana Meaney-Delman and Dr. Katherine Fleming-Dutra from the US CDC presented the evolvement and updates of COVID-19 vaccination guidelines in the United States for pregnant women, emphasizing the data collection, vaccine safety monitoring, and risk-benefit evaluation.<\/p>\n\n\n\n
Dr. Min Wang from Fosun Pharma emphasized the significance of RSV vaccination during the pregnancy, specifically highlighting the efficacy and recommended timing of RSV vaccination to protect infants during seasonal outbreaks.<\/p>\n\n\n\n
Dr. Hong Jiang from School of Public Health, Fudan University, introduced the guidelines and current status of maternal vaccination in China. She reviewed global guidelines and guidelines from other countries, shared research findings to demonstrate the safety and efficacy of maternal vaccines, and encouraged more research to generate evidences to support maternal vaccination and reduce the burden of vaccine-preventable diseases (VPDs).<\/p>\n\n\n\n
Relevant Research and materials:<\/strong><\/p>\n\n\n\n 1.https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html#pregnant<\/em><\/p>\n\n\n\n 2.COVID-NET:https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covid-data\/covid-net\/purpose-methods.html.Data March 1, 2020 through July 22, 2023. Pre-Delta: March 1, 2020 \u2013 June 19, 2021; Delta: June 20\u2013December 18, 2021; Omicron BA.1: December 19, 2021\u2013March 19, 2022; Omicron BA.2: March 20\u2013June 18, 2022; Omicron BA.5 and later (June 19, 2022\u2013October 21, 2023)<\/em><\/p>\n\n\n\n 3.Schrag S J, Verani J R, Dixon B E, et al. Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of Delta and Omicron variant predominance in the United States[J]. JAMA network open, 2022, 5(9): e2233273-e2233273<\/em><\/p>\n\n\n\n 4.Halasa N B, Olson S M, Staat M A, et al. Maternal vaccination and risk of hospitalization for Covid-19 among infants[J]. New England Journal of Medicine, 2022, 387(2): 109-119.<\/em><\/p>\n\n\n\n 5.http:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult-conditions compliant.html<\/p>\n\n\n\n 6.ACIP Evidence to Recommendations Framework (cdc.gov)<\/p>\n\n\n\n 7.M\u00f8lgaard\u2010Nielsen D, Fischer T K, Krause T G, et al. Effectiveness of maternal immunization with trivalent inactivated influenza vaccine in pregnant women and their infants[J]. Journal of internal medicine, 2019, 286(4): 469-480.<\/p>\n","protected":false},"excerpt":{"rendered":" With the support of the Bill & Melinda Gates Foundation and other collaborative stakeholders, VaxLab hosted an online workshop to discuss the safety and efficacy of maternal vaccination, featuring domestic and internationally renowned guest speakers.<\/p>\n","protected":false},"featured_media":9367,"menu_order":0,"template":"","meta":{"type_label":"none_selected"},"news-category":[72],"class_list":["post-10404","project-news","type-project-news","status-publish","has-post-thumbnail","hentry","news-category-news-en"],"_links":{"self":[{"href":"https:\/\/vaxlab.dukekunshan.edu.cn\/en\/wp-json\/wp\/v2\/project-news\/10404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vaxlab.dukekunshan.edu.cn\/en\/wp-json\/wp\/v2\/project-news"}],"about":[{"href":"https:\/\/vaxlab.dukekunshan.edu.cn\/en\/wp-json\/wp\/v2\/types\/project-news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vaxlab.dukekunshan.edu.cn\/en\/wp-json\/wp\/v2\/media\/9367"}],"wp:attachment":[{"href":"https:\/\/vaxlab.dukekunshan.edu.cn\/en\/wp-json\/wp\/v2\/media?parent=10404"}],"wp:term":[{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/vaxlab.dukekunshan.edu.cn\/en\/wp-json\/wp\/v2\/news-category?post=10404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}